THE BioMed Co., Ltd. (KOSDAQ:214610)

THE BioMed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	172.69	13,673	9,354	5,678	23,811	20,855
Short-Term Investments	100	100	13,284	7,744	12,154	3,278
Trading Asset Securities	-	-	-	573.05	-	-
Cash & Short-Term Investments	272.69	13,773	22,638	13,995	35,965	24,133
Cash Growth	-95.44%	-39.16%	61.76%	-61.09%	49.03%	146.55%
Accounts Receivable	591.12	939.66	2,120	1,681	11,065	10,750
Other Receivables	175.43	212	190.43	59.8	127.74	20.65
Receivables	866.55	2,590	10,078	2,304	11,783	11,430
Inventory	5,741	6,973	11,248	17,684	18,751	19,518
Prepaid Expenses	101	226.08	468.01	490.64	951.46	764.88
Other Current Assets	1,001	2,234	2,956	2,058	2,230	1,466
Total Current Assets	7,982	25,797	47,387	36,531	69,681	57,311
Property, Plant & Equipment	11,079	20,239	5,606	10,401	16,058	11,671
Long-Term Investments	1,397	116.36	1,267	8,160	76.46	76.46
Goodwill	-	6,496	5,253	28.77	-	-
Other Intangible Assets	83.66	15.92	778.48	1,140	1,381	842.96
Long-Term Deferred Charges	-	-	-	-	0	13.45
Other Long-Term Assets	11,509	1,655	861.96	697.03	981.6	645.01
Total Assets	32,223	54,467	61,318	57,512	88,677	70,960
Accounts Payable	180.8	259.23	838.24	358.29	846.36	1,643
Accrued Expenses	152.77	210.32	649.75	231.82	278.72	261.2
Short-Term Debt	5,566	5,776	1,258	7,000	7,000	3,078
Current Portion of Long-Term Debt	-	2,683	6,601	9,546	-	0
Current Portion of Leases	643.15	867.96	872.36	740.79	1,161	618.94
Current Income Taxes Payable	-	37.19	-	-	-	-
Other Current Liabilities	4,299	3,808	7,316	9,553	2,437	3,274
Total Current Liabilities	10,842	13,641	17,535	27,430	11,723	8,875
Long-Term Debt	0	9,720	2,579	3,376	7,968	65.72
Long-Term Leases	1,183	2,361	2,351	2,619	6,036	2,973
Long-Term Deferred Tax Liabilities	-	428.66	87.55	100.52	113.49	126.46
Other Long-Term Liabilities	316.2	894.69	279.49	4,327	7,365	535.6
Total Liabilities	13,300	28,581	24,989	39,872	36,444	15,017
Common Stock	2,575	25,753	21,784	9,154	9,148	9,076
Additional Paid-In Capital	187,901	164,728	146,592	113,582	111,284	104,034
Retained Earnings	-169,578	-162,692	-131,730	-105,855	-68,225	-57,044
Treasury Stock	-51.84	-23.87	-23.87	-13.36	-19.55	-19.55
Comprehensive Income & Other	-1,923	-1,880	357.99	825.94	71.06	-84.41
Total Common Equity	18,923	25,885	36,981	17,693	52,259	55,961
Minority Interest	0.02	0.04	-651.96	-53.48	-25.29	-19.36
Shareholders' Equity	18,923	25,885	36,329	17,639	52,234	55,942
Total Liabilities & Equity	32,223	54,467	61,318	57,512	88,677	70,960
Total Debt	7,392	21,407	13,660	23,282	22,164	6,736
Net Cash (Debt)	-7,120	-7,634	8,977	-9,287	13,801	17,397
Net Cash Growth	-	-	-	-	-20.67%	-
Net Cash Per Share	-1496.69	-1750.50	3627.78	-4229.49	6296.86	9941.62
Filing Date Shares Outstanding	5.14	5.15	4.36	2.2	2.19	2.18
Total Common Shares Outstanding	5.14	5.15	4.36	2.2	2.19	2.18
Working Capital	-2,860	12,156	29,852	9,101	57,958	48,436
Book Value Per Share	3678.91	5026.60	8489.70	8055.19	23809.35	25699.99
Tangible Book Value	18,839	19,373	30,949	16,525	50,878	55,118
Tangible Book Value Per Share	3662.65	3762.10	7105.03	7523.25	23180.20	25312.87
Land	-	4,946	-	1,169	1,169	1,151
Buildings	-	11,010	-	1,669	1,669	1,644
Machinery	6,214	6,563	8,322	8,320	8,075	6,880
Construction In Progress	8,307	127.1	184.24	267.4	526.82	294.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.